Cell surface expression of PD-L1 can be upregulated on both tumor cells and other cell types after treatment with type I or type II interferons (IFNs) [29, 30], radiation [31–33], or chemotherapy [34–38]. This evidence concerns the gene CD274 and neoplasm.